These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15188566)

  • 1. [Correction of intestinal dysbacteriosis in elderly patients with the use of bifidobacterin introduced by different routes].
    Chulok TA; Kaverina KG; Shumova SL; Matsulevich TV; Doroshenko EO
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):76-8. PubMed ID: 15188566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A trial of using a dry bifidobacterin preparation with newborn risk groups to prevent acute intestinal infections].
    Chernysheva NA; Mel'nikova KI; Finkel' MP; Izotova ZB
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):37-9. PubMed ID: 8017124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The microecological disorders in clinical pathology and their correction by bifidum-containing probiotics].
    Vorob'ev AA; Bondarenko VM; Lykova EA; Grigor'ev AV; Matsulevich TM
    Vestn Ross Akad Med Nauk; 2004; (2):13-7. PubMed ID: 15101202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiology of acute enteric infection in children with arid zone and effect of probiotics].
    Utemuradova GE
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):98-100. PubMed ID: 19623719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy of using an immune lactoglobulin preparation for correcting intestinal dysbacteriosis in newborn infants].
    Kushnareva MV; Keshishian ES; Soboleva SV
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (2):101-4. PubMed ID: 7653120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The dysbacteriosis of extreme states].
    Liz'ko NN
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):184-6. PubMed ID: 3579245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The possibilities for correcting the dysbacteriosis occurring in the prolonged external diversion of bile].
    Shor-Chudnovskiĭ ME; Susak IaM; Grigor'ev AV; Kurik MV; Shelkovaia NG
    Klin Khir (1962); 1993; (11):30-2. PubMed ID: 8207906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of bifidumbacterin in young children with acute intestinal diseases].
    Protoklitova NS; Sterligova ND; Naumova MA; Romanov MV
    Vopr Okhr Materin Det; 1977; 22(2):54-8. PubMed ID: 841947
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of sporulating bacteria in treating patients with dysbacteriosis].
    Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA
    Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestinal dysbacteriosis in yersiniosis patients and the possibility of its correction with biopreparations].
    Kuznetsov VF; Iushchuk ND; Iurko LP; Nabokova NIu
    Ter Arkh; 1994; 66(11):17-8. PubMed ID: 7900004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of fermented-milk bifidumbacterin on the intestinal microflora of test pilots].
    Kafarskaia LI; Glad'ko IA; Efimov BA; Tarabrina NP; Skvortsov VM; Korshunov VM
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Apr; (4):12-4. PubMed ID: 1496870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intestinal microflora of monkeys, normal and in pathology, and its correction by preparations of live bacteria from human biocenosis (coli bacteria, bifikol and bifidum bacterin)].
    Dzhikidze EK; Shaginian SA; Pospelova VV; Rakhimova NG; Voroshilina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Dec; (12):44-8. PubMed ID: 6397016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience of pediatric application of bifidumbacterin multi, a biologically active food supplement].
    Amerkhanova AM; Lavrova AE; Dmitrieva GV; Pyrikova IA; Zubkova ES; Zhilenkova OG; Kuralenko AA
    Vestn Ross Akad Med Nauk; 2005; (12):30-2. PubMed ID: 16404980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of loading doses of bifidumbacterin forte for treatment of patients with acute enteric infections].
    Korviakova EP
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):58-61. PubMed ID: 11210639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monkeys as subjects for study of immunobiological preparations].
    Aleshkin VA; Lapin BA; Afanas'ev SS; Pospelova VV; Dzhikidze EK; Afanas'ev MS
    Vestn Ross Akad Med Nauk; 2006; (2):11-5. PubMed ID: 16544898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoglobulin and lysozyme content in the intestines during correction of the dysbacteriosis of acute leukemia patients].
    Martynova VA; Tolkacheva TV; Abakumov EM; Golosova TV
    Vopr Onkol; 1981; 27(7):39-43. PubMed ID: 6943866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of bifidumbacterin for the correction of intestinal dysbacteriosis].
    Liz'ko NN; Goncharova GI
    Kosm Biol Aviakosm Med; 1987; 21(4):70-2. PubMed ID: 3657069
    [No Abstract]   [Full Text] [Related]  

  • 18. [The efficacy of using bifidokefir for the treatment of acute intestinal infections and for the correction of dysbacterosis in children].
    Murashova AO; Novokshonov AA; Uchaĭkin VF
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):108-10. PubMed ID: 7879497
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correction of intestinal dysbacteriosis with biological preparations in acute leukemia].
    Tolkacheva TV; Abakumov EM; Martynova VA; Golosova TV
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):29-33. PubMed ID: 7279892
    [No Abstract]   [Full Text] [Related]  

  • 20. [The microbiocenosis of the intestines and its influence on the course of postenterocolitic reactive arthritis].
    Rubtsov OV; Bevz NI; Agababova ER; Goncharova GI
    Revmatologiia (Mosk); 1990; (2):46-50. PubMed ID: 2218264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.